VMI
ARCT icon

VHCP Management II’s Arcturus Therapeutics ARCT Stock Holding History

VHCP Management II’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-26,449
Closed -$211K – 20
2017
Q1 		$211K Sell
26,449
-193,189
-88% -$1.79M 0.09% 19
2016
Q4 		$3.23M Hold
219,638
– – 1.55% 14
2016
Q3 		$3.8M Buy
219,638
+11,866
+6% +$383K 1.95% 12
2016
Q2 		$6.53M Buy
207,772
+46,272
+29% +$1.46M 3.94% 8
2016
Q1 		$4.29M Hold
161,500
– – 2.82% 12
2015
Q4 		$7.1M Buy
+161,500
New +$7.27M 5.83% 6

Other funds holding ARCT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

VHCP Management II's ARCT Position: Q2 2017 in Review

VHCP Management II sold out of Arcturus Therapeutics (ARCT) in Q2 2017, closing a stake of 26,449 shares — an estimated $211K sold.

VHCP Management II first reported a position in ARCT in Q4 2015 and held it in 6 quarters. The position peaked at $7.1M in Q4 2015. 23 funds tracked by Wall St. Rank hold ARCT as of Q2 2017.

  • VHCP Management II reported no remaining Arcturus Therapeutics position as of Q2 2017 after selling out during the quarter.
  • VHCP Management II sold 26,449 Arcturus Therapeutics shares in Q2 2017, an estimated $211K.
  • VHCP Management II first reported a position in Arcturus Therapeutics in Q4 2015 and held it in 6 quarters.
  • VHCP Management II's Arcturus Therapeutics position peaked at $7.1M in Q4 2015.
  • 23 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2017.

Based on VHCP Management II's 13F filing for Q2 2017, filed 11 Aug 2017.